JESSICA JANAS: Open Payments
NPI 1356003214 · MINDEN, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,887 in 88 payments from 16 companies in 2025. Trend: 2023 $631 · 2024 $1,371 · 2025 $1,887
Food & beverage: $1,887
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $530 |
| AstraZeneca Pharmaceuticals LP | 11 | $392 |
| Novo Nordisk Inc | 21 | $273 |
| PFIZER INC. | 11 | $210 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| Lundbeck LLC | 3 | $73 |
| Axsome Therapeutics, Inc. | 3 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| Lilly USA, LLC | 2 | $38 |
| Exact Sciences Corporation | 2 | $31 |
Products named: VRAYLAR, BREZTRI, Ozempic, NURTEC ODT, Rybelsus, UBRELVY, REXULTI, TRELEGY ELLIPTA.
Industry payments across NV — which companies pay providers there.
